These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26688186)

  • 1. A new biomarker for Parkinson's disease?
    Williams-Gray CH
    Mov Disord; 2016 Jan; 31(1):42. PubMed ID: 26688186
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.
    Locascio JJ; Eberly S; Liao Z; Liu G; Hoesing AN; Duong K; Trisini-Lipsanopoulos A; Dhima K; Hung AY; Flaherty AW; Schwarzschild MA; Hayes MT; Wills AM; Shivraj Sohur U; Mejia NI; Selkoe DJ; Oakes D; Shoulson I; Dong X; Marek K; Zheng B; Ivinson A; Hyman BT; Growdon JH; Sudarsky LR; Schlossmacher MG; Ravina B; Scherzer CR
    Brain; 2015 Sep; 138(Pt 9):2659-71. PubMed ID: 26220939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for differential methylation of α-synuclein in leukocyte DNA of Parkinson's disease patients.
    Richter J; Appenzeller S; Ammerpohl O; Deuschl G; Paschen S; Brüggemann N; Klein C; Kuhlenbäumer G
    Mov Disord; 2012 Apr; 27(4):590-1. PubMed ID: 22262231
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of alpha-synuclein mRNA in Parkinson's disease.
    Papapetropoulos S; Adi N; Mash DC; Shehadeh L; Bishopric N; Shehadeh L
    Mov Disord; 2007 May; 22(7):1057-9; author reply 1057. PubMed ID: 17373725
    [No Abstract]   [Full Text] [Related]  

  • 5. Extracellular α-synuclein--a possible initiator of inflammation in Parkinson's disease.
    Ren WQ; Tian ZM; Yin F; Sun JZ; Zhang JN
    Pharmazie; 2016 Feb; 71(2):51-5. PubMed ID: 27004367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein-based models of Parkinson's disease.
    Dehay B; Fernagut PO
    Rev Neurol (Paris); 2016; 172(6-7):371-8. PubMed ID: 27158042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era.
    Visanji NP; Brotchie JM; Kalia LV; Koprich JB; Tandon A; Watts JC; Lang AE
    Trends Neurosci; 2016 Nov; 39(11):750-762. PubMed ID: 27776749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of Parkinson's disease: alpha-synuclein and other insights from Greece.
    Proukakis C
    Eur J Neurol; 2014 Jul; 21(7):946-7. PubMed ID: 24460978
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and neuroimaging features of patient with early-onset Parkinson's disease with dementia carrying SNCA p.G51D mutation.
    Tokutake T; Ishikawa A; Yoshimura N; Miyashita A; Kuwano R; Nishizawa M; Ikeuchi T
    Parkinsonism Relat Disord; 2014 Feb; 20(2):262-4. PubMed ID: 24315198
    [No Abstract]   [Full Text] [Related]  

  • 10. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.
    Pavlou MAS; Pinho R; Paiva I; Outeiro TF
    Brain; 2017 Apr; 140(4):878-886. PubMed ID: 27585855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interaction.
    Goldman SM; Umbach DM; Kamel F; Tanner CM
    Eur J Neurol; 2015 Jul; 22(7):e75. PubMed ID: 26060929
    [No Abstract]   [Full Text] [Related]  

  • 12. The behavior of alpha-synuclein in neurons.
    Fortin DL; Nemani VM; Nakamura K; Edwards RH
    Mov Disord; 2010; 25 Suppl 1():S21-6. PubMed ID: 20187244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication.
    Orimo S; Uchihara T; Nakamura A; Mori F; Ikeuchi T; Onodera O; Nishizawa M; Ishikawa A; Kakita A; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2008 Nov; 116(5):575-7. PubMed ID: 18751989
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease.
    Huang Y; Rowe DB; Halliday GM
    J Parkinsons Dis; 2011; 1(3):271-6. PubMed ID: 23939307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro.
    Schmitt I; Kaut O; Khazneh H; deBoni L; Ahmad A; Berg D; Klein C; Fröhlich H; Wüllner U
    Mov Disord; 2015 Nov; 30(13):1794-801. PubMed ID: 26173746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease.
    Deng H; Xie W; Guo Y; Le W; Jankovic J
    Mov Disord; 2006 May; 21(5):728-9. PubMed ID: 16552756
    [No Abstract]   [Full Text] [Related]  

  • 17. Flies with Parkinson's disease.
    Vanhauwaert R; Verstreken P
    Exp Neurol; 2015 Dec; 274(Pt A):42-51. PubMed ID: 25708988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Synuclein at the synaptic gate.
    Surmeier DJ
    Neuron; 2010 Jan; 65(1):3-4. PubMed ID: 20152107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Rocha EM; De Miranda B; Sanders LH
    Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
    Benskey MJ; Perez RG; Manfredsson FP
    J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.